Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Related Articles by Review for PubMed (Select 18586690)

1.

Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo.

Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN, Hursting SD.

Carcinogenesis. 2008 Oct;29(10):2001-10. doi: 10.1093/carcin/bgn131. Epub 2008 Jun 26.

2.

Resveratrol: a candidate nutritional substance for prostate cancer prevention.

Stewart JR, Artime MC, O'Brian CA.

J Nutr. 2003 Jul;133(7 Suppl):2440S-2443S. Review.

3.

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.

Kundu JK, Surh YJ.

Cancer Lett. 2008 Oct 8;269(2):243-61. doi: 10.1016/j.canlet.2008.03.057. Epub 2008 Jun 11. Review.

PMID:
18550275
4.

Resveratrol: a review of preclinical studies for human cancer prevention.

Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL.

Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83. Epub 2007 Jan 3. Review.

5.

Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Hsieh TC, Wu JM.

Biofactors. 2010 Sep-Oct;36(5):360-9. doi: 10.1002/biof.105. Review.

6.

Resveratrol--a prostate cancer chemopreventive agent?

Ratan HL, Steward WP, Gescher AJ, Mellon JK.

Urol Oncol. 2002 Nov-Dec;7(6):223-7. Review.

PMID:
12504842
7.

Resveratrol-sulfates provide an intracellular reservoir for generation of parent resveratrol, which induces autophagy in cancer cells.

Andreadi C, Britton RG, Patel KR, Brown K.

Autophagy. 2014 Mar;10(3):524-5. doi: 10.4161/auto.27593. Epub 2014 Jan 9. Review.

8.

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake.

Jannin B, Menzel M, Berlot JP, Delmas D, Lançon A, Latruffe N.

Biochem Pharmacol. 2004 Sep 15;68(6):1113-8. Review.

PMID:
15313407
9.

Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum.

Gescher AJ, Steward WP.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):953-7. Review. No abstract available.

10.

Resveratrol and cancer: focus on in vivo evidence.

Carter LG, D'Orazio JA, Pearson KJ.

Endocr Relat Cancer. 2014 May 6;21(3):R209-25. doi: 10.1530/ERC-13-0171. Print 2014 Jun. Review.

11.

Resveratrol in prostate diseases - a short review.

Jasiński M, Jasińska L, Ogrodowczyk M.

Cent European J Urol. 2013;66(2):144-9. doi: 10.5173/ceju.2013.02.art8. Epub 2013 Aug 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk